https://www.indianpharmapost.com/adopt-digitisation-automation-for-business-sustainability-and-quality-excellence-ceos-114552022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/thermo-fisher-scientific-extends-partnership-with-symphogen-to-support-biopharma-114682022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-launches-sevelamer-hydrochloride-tablets-in-the-united-states-114672022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/south-koreas-oci-acquires-11-stake-in-bukwang-pharmaceutical-114662022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/synapse-medicine-raises-us-28-million-to-scale-its-medication-reconciliation-platform-114652022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/idt-biologika-collaborates-with-exothera-to-push-forward-the-scale-up-of-viral-vaccines-114642022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/bruker-releases-ccs-enabled-timscore-and-tims-dia-nn-4d-proteomics-software-114632022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/innovent-biologics-and-anheart-therapeutics-receive-nmpa-breakthrough-designation-for-taletrectinib-114622022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-and-neurimmune-enter-licencing-agreement-to-develop-and-commercialise-ni006-114612022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/boehringer-ingelheim-partners-with-lifebit-to-capture-health-data-114602022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/novavax-uk-phase-3-trial-demonstrates-protection-from-covid-19-over-six-month-period-114592022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/bristol-myers-squibbs-application-for-opdivo-plus-chemotherapy-receives-usfda-priority-review-114582022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/medvarsity-partners-with-clove-dental-to-launch-fellowship-in-endodontics-114572022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/singapore-first-to-top-whos-classification-of-medical-regulator-114562022-03-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-citi-biopharmas-vonjo-114692022-03-01T00:00:00+05:30always0.9